Yiwei Li Selected Research

Antioxidants

1/2015	The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.
1/2014	Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.
7/2013	Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?
1/2012	Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.
10/2008	Multi-targeted therapy of cancer by genistein.
1/2003	Soy isoflavones and cancer prevention.
1/2002	Mechanisms of cancer chemoprevention by soy isoflavone genistein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiwei Li Research Topics

Disease

118	Neoplasms (Cancer) 05/2024 - 01/2002
40	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 01/2002
31	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2002
30	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 05/2004
17	Inflammation (Inflammations) 03/2024 - 01/2008
17	Carcinogenesis 11/2023 - 01/2002
10	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2003
7	Body Weight (Weight, Body) 03/2024 - 01/2020
7	Metabolic Diseases (Metabolic Disease) 04/2023 - 01/2020
6	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2018
5	Dysbiosis 07/2023 - 02/2020
5	Hypoxia (Hypoxemia) 03/2021 - 01/2012
4	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 09/2022
4	COVID-19 01/2023 - 08/2020
4	Insulin Resistance 02/2020 - 04/2011
3	Severe Acute Respiratory Syndrome 09/2023 - 06/2009
3	Atrophy 12/2021 - 01/2021
3	Cachexia 12/2021 - 01/2021
3	Shock 08/2018 - 07/2004
2	Pain (Aches) 04/2024 - 01/2023
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 03/2024 - 10/2022
2	Lymphoma (Lymphomas) 02/2024 - 12/2021
2	Adenocarcinoma 12/2023 - 01/2019
2	Carcinoma (Carcinomatosis) 11/2023 - 03/2006
2	Dental Caries (Decay, Dental) 01/2023 - 01/2020

Drug/Important Bio-Agent (IBA)

39	MicroRNAs (MicroRNA)IBA 01/2024 - 04/2008
31	NF-kappa B (NF-kB)IBA 07/2013 - 07/2002
27	IsoflavonesIBA 10/2013 - 01/2002
24	GenisteinIBA 01/2014 - 01/2002
17	3,3'-diindolylmethane (diindolylmethane)IBA 01/2016 - 04/2003
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2002
13	CurcuminIBA 01/2013 - 11/2004
11	Transcription Factors (Transcription Factor)IBA 11/2022 - 04/2003
10	AndrogensIBA 01/2018 - 01/2002
10	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 10/2006
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 12/2002
9	Hormones (Hormone)IBA 10/2011 - 03/2004
9	indole-3-carbinolIBA 06/2010 - 01/2003
8	LipopolysaccharidesIBA 03/2024 - 07/2004
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2003
7	Phosphotransferases (Kinase)IBA 10/2023 - 07/2002
7	Therapeutic UsesIBA 01/2023 - 03/2004
7	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 01/2005
7	AntioxidantsIBA 01/2015 - 01/2002
7	Docetaxel (Taxotere)FDA Link 05/2006 - 03/2004
6	Gemcitabine FDA Link 12/2023 - 09/2003
6	Complementary DNA (cDNA)IBA 07/2010 - 12/2002
6	Matrix Metalloproteinases (MMPs)IBA 12/2007 - 12/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 01/2006
4	InterleukinsIBA 03/2024 - 01/2020
4	Butyrates (Butyrate)IBA 03/2024 - 10/2022
4	selinexorIBA 12/2023 - 10/2017
4	Apolipoproteins E (ApoE)IBA 07/2023 - 01/2021
4	Estrogens (Estrogen)FDA Link 01/2020 - 01/2002
4	Small Interfering RNA (siRNA)IBA 02/2015 - 03/2006
4	Epithelial Cell Adhesion MoleculeIBA 08/2014 - 08/2011
4	Cisplatin (Platino)FDA LinkGeneric 04/2006 - 05/2004
3	Exportin 1 ProteinIBA 12/2023 - 10/2017
3	CateninsIBA 11/2023 - 10/2021
3	CholesterolIBA 01/2023 - 01/2020
3	CytokinesIBA 12/2022 - 06/2007
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2020
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2021
3	Linseed Oil (Flaxseed Oil)IBA 01/2022 - 01/2020
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2022 - 01/2020
3	LipidsIBA 01/2022 - 01/2014
3	p21-Activated KinasesIBA 12/2021 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 06/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2012
3	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 04/2011
3	Insulin (Novolin)FDA Link 02/2020 - 04/2011
3	HMGB1 Protein (HMG1)IBA 08/2018 - 06/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2013 - 08/2006
3	Platelet-Derived Growth FactorIBA 08/2010 - 12/2007
3	Jagged-1 ProteinIBA 03/2010 - 11/2006
3	LigandsIBA 03/2010 - 11/2006
3	thiazolyl blueIBA 09/2007 - 03/2006
3	matrigelIBA 04/2007 - 03/2006
3	Epidermal Growth Factor (EGF)IBA 01/2005 - 07/2002
2	Cadherins (E-Cadherin)IBA 05/2024 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 03/2024 - 01/2020
2	Blood Proteins (Serum Proteins)IBA 03/2024 - 12/2009
2	CreatinineIBA 03/2024 - 03/2022
2	NitrogenIBA 03/2024 - 01/2021
2	Urea (Carbamide)FDA LinkGeneric 03/2024 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 01/2023
2	Particulate MatterIBA 09/2023 - 02/2023
2	Peptides (Polypeptides)IBA 05/2023 - 12/2002
2	Tight Junction ProteinsIBA 04/2023 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2023 - 04/2011
2	Volatile Fatty AcidsIBA 04/2023 - 01/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2021

Therapy/Procedure

60	Therapeutics 04/2024 - 12/2004
9	Chemoprevention 07/2013 - 01/2002
8	Drug Therapy (Chemotherapy) 11/2022 - 04/2006
6	Radiotherapy 01/2023 - 04/2006
4	Catheters 01/2019 - 01/2018
3	Oral Administration 01/2022 - 03/2012
3	Castration 06/2021 - 02/2015
2	Transcranial Magnetic Stimulation 04/2024 - 01/2023